Literature DB >> 20417718

Evaluation of mutagenic activity of the organo-selenium compound Selol by use of the Salmonella typhimurium mutagenicity assay.

I Rahden-Staroń1, P Suchocki, H Czeczot.   

Abstract

We examined the mutagenic activity of the anti-oxidant Selol, an organo-selenium compound, by use of the Salmonella typhimurium mutagenicity assay (Ames test) with strains TA97a, TA98, TA100, TA 1535 and TA102 in the absence and in the presence of metabolic activation with an S9 fraction from Aroclor-induced rat liver. Doses were 330, 500, 1000 and 5000 microg per plate. Selol contains the element selenium (valency, +4) in its structure and it may have chemopreventive and anticancer activity. Selol was found to be non-toxic and non-mutagenic for test doses up to 5% per plate (which designates the declared content of Selenium (+4) as 5000 microg per plate) in all the S. typhimurium strains. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417718     DOI: 10.1016/j.mrgentox.2010.04.018

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Protective Effects of Selol Against Sodium Nitroprusside-Induced Cell Death and Oxidative Stress in PC12 Cells.

Authors:  Agnieszka Dominiak; Anna Wilkaniec; Piotr Wroczyński; Henryk Jęśko; Agata Adamczyk
Journal:  Neurochem Res       Date:  2016-09-02       Impact factor: 3.996

Review 2.  Selenium Compounds as Novel Potential Anticancer Agents.

Authors:  Dominika Radomska; Robert Czarnomysy; Dominik Radomski; Krzysztof Bielawski
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 6.208

Review 3.  Selenium in the Therapy of Neurological Diseases. Where is it Going?

Authors:  Agnieszka Dominiak; Anna Wilkaniec; Piotr Wroczyński; Agata Adamczyk
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.